WWW.DISSERTATION.XLIBX.INFO
FREE ELECTRONIC LIBRARY - Dissertations, online materials
 
<< HOME
CONTACTS



Pages:     | 1 |   ...   | 4 | 5 || 7 | 8 |   ...   | 11 |

«11-18-2012 An Organizational Diagnosis Of A Centralized Investigational New Drug Core Within A Large Academic Health Center Kathleen M. Thomas ...»

-- [ Page 6 ] --

Participant 002 has been a staff member of the department since 2000. Her role in the department is to ensure regulatory compliance, assist Investigators in preparation of audits, and serve as a liaison between the department regulatory committees, and the IRB.

Participant 003 was a part of the department for about five years before moving on to a different AHC. Along with numerous other tasks (clinical and research), he was charged with maintaining a senior leadership role within the IND core.

Participant 004 supports the IND core by writing the Chemistry, Manufacturing, and Control (CMC) sections of the IND application, supplies drug accountability, and manufactures the IND related Radio-pharmaceuticals.

Participant 005 has been with the University for nearly twenty-five years and is responsible for overseeing research within the department. He assumed the role of Sponsor at the start of 2011.

I decided not to interview two groups of individuals from the background interview process: past Sponsor-Investigators, and personnel from OHR. The first group includes four previous Sponsor-Investigators. I decided not to interview these four individuals because I did not believe they would be able to provide me with the specific reasons for centralizing INDs nor insight into the current operational structure of the core.

While their input and perspectives of the core is valuable, I did not believe it was relevant to this capstone. The data I am attempting to collect is to determine the operational effectiveness within the current centralized core.

The other group I will not interview personnel of OHR. The previous Director, who was involved with the development of the centralized office, is no longer an employee of the organization, and I did not have a way to contact this individual. The remaining individuals of OHR had limited involvement with the development and implementation of the core. In addition, one individual was not employed with the organization at the time of implementation. I made the decision to exclude these individuals based on the above noted factors.

Interview protocol I will use a seven-question structured interview process (Appendix A). There are six structured questions and one open-ended question which allow the participants to provide additional information about the history of the IND core. The purpose of the background interviews is to gain an understanding of the history behind the development and implementation of the centralization. The content of the questions focuses on the following: the structure of INDs prior to centralization, when the idea was born, what the rationale was, who led the redesign, the vision of the centralized core, and the communication mechanisms used to inform Investigators of the change.

Question one: Can you provide information on the operational structure of the IND core prior to the implementation of the centralized model? I framed the first question to learn about the operational structure of IND related research within the department prior to centralization. I wanted to hear from the core members how they perceived the way in which decentralization was operating. My hope with these responses is to determine how the IND related protocols were managed prior to centralization.

Question two: When did the idea of a centralized IND core come about? This question is designed to learn when the idea was first born. I want to learn of the time period for this thought process.

Question three: What was the rationale for creating a centralized IND core? The third question is designed to learn what caused the department to change to a centralized structure.

Question four: Who led the re-design of the IND core? The fourth question is designed to gain insight as to whether the leader of the redesign was an individual or group.

Question five: How did you envision the operational structure of the centralized IND core? The fifth question is designed to learn the intended structure of the centralization. I would like to understand how the leader (and those selected to be members of the core) planned to manage the associated responsibilities of a centralized service.

Question six: What mechanism(s) did you use to inform Investigators throughout the University of the Re-design of the IND core? The sixth question is designed to learn what mechanism was used to inform previous (and future) Sponsor-Investigators of the planned centralized core. With these responses, I intend to gain an understanding of how individuals were informed of the new process.

Question seven: Is there additional information about the background development of the IND core that has not been discussed so far in this interview? The seventh question is designed to be open-ended and allow the participant to provide additional information about the background of the core.

I will contact each participant via email requesting their participation in the interview. After agreement to participate, I plan to schedule private individual interviews with the five participants. I will meet with three of the participants in person, and two on the telephone due to distance. At the beginning of each interview, I will remind each participant that their participation is voluntary and the interview will be stopped at any time if they feel uncomfortable.

I will take extensive hand-written notes during the interviews. These notes will include documentation of responses, observation of tone, and body language. At the conclusion of each interview I will write some field notes which will include my thoughts and feelings about the interview.





Current state interviews In order to fully evaluate the effectiveness of the centralized IND core, I will conduct in-depth interviews with three current staff members of the IND core as well as one external member. I selected the administrative manager, the sponsor's authorizedrepresentative and the cyclotron production manager for participation in these interviews.

I selected these individuals as their roles keep the core functioning.

There are three groups that will not be interviewed for this capstone: Radiologists, Investigators using the core, and administrative staff of OHR. I decided to exclude these groups for a variety of reasons, but mainly because their involvement with the core is limited. The Radiologists are called upon to provide scientific input for drugs that are new to the core. A new IND has not been written or submitted within the last two years therefore, their expertise has not been needed often. They are responsible for collaborating with non-departmental Investigators on the conduct of the radiopharmaceutical component of the protocol, as well as for administering the radiopharmaceutical. I selectively excluded this group; they are indirectly involved with the aspects of the core.

The second group I decided not to interview for this capstone is Investigators and research staff who utilize the IND core services. These individuals are valuable to our core as they request our services and keep the core running. To my knowledge, there has only been one complaint about the effectiveness of the centralized core. The complaint was duplicate efforts were occurring. The Investigator held an IND for a separate drug (one not produced by this department). Since this was the only complaint I am aware of, I did not believe interviewing Investigators would provide much useful information for the purposes of my data collection. Their opinions and comments are valuable however; the focus of my data collection is on the internal infrastructure of the core.

Administrative personnel from OHR were not interviewed as well. I decided to exclude these individuals because their expertise is needed if the members of our core need assistance with regulatory guidelines. These individuals are not a part of the daily operations or infrastructure of the core. Due to their limited involvement I will not include this group in the interview process.

Interview protocol There are ten questions included in this current state interview protocol (Appendix B). Of the ten, seven questions are open-ended as I want to investigate my underlying assumptions. The remaining three questions are close-ended questions. If I feel additional information is needed at the time of the interview, I will ask the participant to elaborate on their response. The content of the questions is centered on the current operational structure of the core. Because the purpose of these interviews is to hear from each key member their perspective on the current state and learn if they are aware of a future plan for growth, the questions are framed to facilitate my understanding of each participant’s perception.

Question one: can you give me an example of what is working well about the IND core? This question uses an appreciative inquiry type format. I would like to hear from each key member their view about the strength of the core.

Question two: How would you describe your role within the IND core? This question is designed to ask each participant their role in the core. I want to understand how they view their role in the core, as well as their role with the other core members.

The purpose of the question is to confirm or disprove my hypothesis that the core is not operating in the way it was structured to operate.

Question three: Can you provide information on the current operational structure of the IND core? This question is designed to learn from each participant the current operational structure of the core. My intention with this question is to learn more of the daily operations from the perspective of each participant.

Question four: What is the mission of the IND core? This question is designed to learn how each participant views the mission of the core. The purpose of this question is to determine if the perceived mission is viewed similarly among all participants.

Question five: Is the IND core satisfying all responsibilities associated with the role of Sponsor? This question is designed to learn if the core is satisfying all responsibilities. The intent with this question is to determine if each participant is aware of unfulfilled responsibilities.

Question six is: What are the number of INDs currently active under the core?

What are the number of protocols currently active under the core? This is designed to determine if each member is aware of the number of IND's and protocols being held within the core. The purpose of this question is to determine if each participant is aware of how the core has grown over the past few years.

Questions seven: Do you have a limit on the number of INDs and/or protocols your core will support? and question eight: How do you plan to handle management of additional INDs/protocols? These questions are designed to learn about the projected future of the core. My goal with these two questions is to determine two things: if the core has set a limit on the number of INDs and/or protocols it will manage, and if plans are being developed for the future of the core.

Question nine: What mechanism(s) are currently in place to inform potential Investigators of your core? This question is designed to learn about the communication mechanisms (or lack of) in place to notify potential Investigators of the services. I want to know if there is an effective process in place to inform Investigators of the core services.

The purpose of this question is to learn more from each participant of the structure.

Question ten: Is there additional information about the IND core that has not been discussed so far in this interview that you would like to add? The purpose of question ten is to allow the participant to provide additional information that was not covered in the above structured interview questions.

I will contact each participant via email informing them of the purpose of this capstone and requesting their participation in the interview process. I plan to conduct inperson interviews in a private office within the department. All participants are employees of the organization and should be available to meet in person.

At the beginning of the interview, I will remind each participant of their right as a participant and the plan for maintaining confidentiality. I plan to record each interview with a tape recorder and document the responses to each question on paper, and include observations of tone, and body language. At the conclusion of each interview, I will document my thoughts and feelings from the interview.

Confidentiality In order to maintain privacy of the participants involved in the interviews, all identifiable information (organization name and location, participant names, and titles) has been removed from this capstone. The organization has been assigned a fictional name, and each participant has been assigned a unique participant ID number.

The documented notes and tape records will be stored in a secure cabinet outside of the office. The purpose for securing these documents is to maximize the participant’s privacy. At the completion of this capstone (November 2012), the notes and tape recordings will be destroyed.

Other information In addition to conducting interviews, I examined multiple documents relevant to the IND core (Appendix D). I reviewed and compared audit reports pre and post centralization. In addition, job descriptions of the IND core manager, and correspondences with the FDA of the change in Sponsorship were reviewed.

My role My role within this capstone is two-fold: participant and observer. I have been a member of the organization for ten years and spent the past two years as an active participant in the IND core. My role within the core is to oversee and assist with building the operational structure and supervise one of the staff members. My direct supervisor is one of the interviewees and the others are colleagues that I have worked with for the past ten years.

Due to my leadership role within the core, I am involved in the daily operations and responsible for promoting the mission of the core, as well as finding ways to remove barriers for my staff and other members of the core.

Throughout my two years leading this core, I have often observed ways in which the structure of the core is flawed. I stepped into the position without fully understanding the level of complexity involved with the role of a Sponsor and did not have a clear understanding of each individual's role within the core. Soon after my involvement began, I hired the IND manager with a narrow understanding of the number of tasks associated with the role of core manager.



Pages:     | 1 |   ...   | 4 | 5 || 7 | 8 |   ...   | 11 |


Similar works:

«The Epilepsy Association of South Australia (EASA) was formed in May 1976, by a group of concerned parents, medical practitioners and interested parties who felt the needs of the person with epilepsy and their families were not being fulfilled. The goals of the organisation were to: Advise and help people with epilepsy  Enlighten the public about the disorder with a view of overcoming ignorance and prejudice  which cause unnecessary hardship to people with epilepsy Encourage medical...»

«MEDICATION GUIDE SYMBICORT 80/4.5 (budesonide 80 mcg and formoterol fumarate dihydrate 4.5 mcg) Inhalation Aerosol SYMBICORT 160/4.5 (budesonide 160 mcg and formoterol fumarate dihydrate 4.5 mcg) Inhalation Aerosol Read the Medication Guide that comes with SYMBICORT before you start using it and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking to your healthcare provider about your medical condition or treatment. What is the most...»

«Department of Health & CMS Manual System Human Services (DHHS) Pub 100-02 Medicare Benefit Policy Centers for Medicare & Medicaid Services (CMS) Transmittal 106 Date: April 24, 2009 Change Request 6381 SUBJECT: Speech-Language Pathology Private Practice Payment Policy I. SUMMARY OF CHANGES: Medicare shall pay for appropriate claims submitted by enrolled speechlanguage pathologists for services provided on or after July 1, 2009. New / Revised Material Effective Date: July 1, 2009 Implementation...»

«  How To Prevent and Treat Arthritis Pain with Nutritional Medicine 1      Limits of Liability/Disclaimer of Warranty The author, Ronald Grisanti and publisher, Sequoia Education Systems have made their best effort to produce a high quality, informative and helpful book. The author and Publisher make no representation or warranties with respect to the accuracy, applicability, fitness or completeness of the contents of this program. They accept no liability of any kind for any losses or...»

«Public Accounts Committee Report on General Report on the Health and Social Care Sector 2012-13 and 2013-14 To g e t he r wi t h t h e Mi n u t e s o f P ro ce ed i n g s o f t h e Co mmi t t e e re l a t in g t o t he Re po rt an d th e Mi nu t e s o f E vi de n ce O rd e re d b y t he Pub l i c A ccou n t s Co mmi t t e e to be p rin t ed o n 2 5 No ve mb e r 2 01 5 This report is the property of the Public Accounts Committee. Neither the report nor its contents should be disclosed to any...»

«(Music) Mark Masselli: This is Conversations on Healthcare, I am Mark Masselli. Margaret Flinter: And I am Margaret Flinter. Mark Masselli: Well Margaret, another key Obama administrator stepping down, Peggy Hamburg, FDA Commissioner for the past 6 years and now she is leaving her post at the end of March saying she does have mixed emotions. Margaret Flinter: Well she certainly wrapped up a number of achievements during her 10-year mark. She worked to modernize food safety over set stricter...»

«Pinaclav 250 mg/125 mg Film-coated Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Pinaclav 250 mg/125 mg Film-Coated Tablets Amoxicillin/Clavulanic acid Read all of this leaflet carefully before you start taking this medicine.Keep this leaflet. You may need to read it again.If you have any further questions, ask your doctor or pharmacist.This medicine has been prescribed for you (or for your child). Do not pass it on to others. It may harm them, even if their symptoms are the same as yours....»

«BLAKELEY HALL Resident Guide 2014 2015 LIVING IN BLAKELEY: A QUICK REFERENCE EMERGENCIES If you have an emergency that requires immediate police or medical attention: • Call 617-627-6911 (from on-campus phones). These phone numbers should be used only for emergencies! For non-emergency police matters, please call 617-627-3030. If you or someone you know in Blakeley has an emergency or is hospitalized, please also contact the Resident Directors. CONTACTING THE BLAKELEY RESIDENT DIRECTORS...»

«Faculty of Health Sciences, Department of Medical Biology, Tumour Biology Research Group Oral Squamous Cell Carcinoma Role of the Plasminogen Activation System in Tumour Progression — Synnøve Norvoll Magnussen A dissertation for the degree of Philosophiae Doctor – Month 20xx Oral Squamous Cell Carcinoma (OSCC) Role of the Plasminogen Activation System in Tumour Progression Doctoral Thesis Synnøve Norvoll Magnussen Tumour Biology Research Group Department of Medical Biology Faculty of...»

«Curriculum Vitae Deepa Bedi, M.D, Ph.D. Assistant Professor Biomedical Sciences 307A, Patterson Hall College of Veterinary Medicine and Allied Health Tuskegee University Tuskegee, AL Email: dbedi@mytu.tuskegee.edu Permanent Resident Status Education Ph.D. 2007 Biomedical Science, Auburn University, Auburn, AL M.D 1998 The Second Tashkent State Medical Institute, Uzbekistan Certification: United States Medical Licensing Examination and Education Commission of Foreign Medical Graduates (ECFMG...»

«Journal of Biology, Agriculture and Healthcare www.iiste.org ISSN 2224-3208 (Paper) ISSN 2225-093X (Online) Vol.3, No.12, 2013 Induced Systemic Resistance in Tomato Plants against Meloidogyne spp by Seed Treatment with β, Amino Butyric Acid and Benzothiadiazol Shamael S. Mutar and Farkad A. Fattah* Department of Plant Protection, College of Agriculture, University of Baghdad,Baghdad,Iraq * E-mail of the corresponding author : farkad.fatah@gmail.com Abstract Treatments of tomato seeds with BABA...»

«BOR Papers in Press. Published on January 15, 2014 as DOI:10.1095/biolreprod.113.113522 Rho-GTPase effector ROCK phosphorylates Cofilin in actin-meditated cytokinesis during mouse oocyte meiosis1 Running Title: ROCK in mouse oocytes Xing Duan,3 Jun-Liu,3 Xiao-Xin Dai,3 Hong-Lin Liu,3 Xiang-Shun Cui,4 Nam-Hyung Kim,4 Zhen-Bo Wang,5 Qiang-Wang,6 Shao-Chen Sun2,3 College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, China Department of Animal Sciences, Chungbuk...»





 
<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.